Ocular Gene Therapy Studies in Primates Needed to Optimize Human Trials

by Dr. Trupti Shirole on  January 3, 2017 at 12:00 AM Research News
RSS Email Print This Page Comment bookmark
Font : A-A+

There are over 285 million visually impaired people in the world, of whom 39 million are blind and 246 million have moderate to severe visual impairment, suggests the World Health Organization.
 Ocular Gene Therapy Studies in Primates Needed to Optimize Human Trials
Ocular Gene Therapy Studies in Primates Needed to Optimize Human Trials

Many gene therapy-based approaches are in development to combat genetic and other causes of blindness and vision loss. Much can be learned about the safety and effectiveness of these promising new therapies by studying them first in non-human primates before initiating clinical trials, suggest the results of a study published in Human Gene Therapy.

A team of researchers led by Jean Bennett, Scheie Eye Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, evaluated and compared two adeno-associated virus (AAV) vectors designed to deliver therapeutic genes directly to the eye when administered via subretinal injection to non-human primates.

They report the differences in gene expression efficiency and immunogenicity across different doses in the article entitled "Evaluation of Dose and Safety of AAV7m8 and AAV8BP2 in the Non-human Primate Retina."

Gene therapies developed and tested in mice may present quite different safety and efficacy profiles when administered to humans. Evaluating gene delivery vectors in non-human primates provides results that are more predictive of what one can expect in humans.

"Dr. Bennett and her team have already made major breakthroughs in gene therapy for genetic causes of blindness. The work published here promises to greatly improve the technology for ocular gene therapy," says Editor-in-Chief Terence R. Flotte, Celia and Isaac Haidak Professor of Medical Education and Dean, Provost, and Executive Deputy Chancellor, University of Massachusetts Medical School, Worcester, MA.

Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions
Advertisement

More News on:

DNA Finger Printing Reiki and Pranic Healing Genetic Testing of Diseases Pancreas Weaver Syndrome Inborn Errors of Metabolism 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive